2,2-dimethyl-N-[(7S)-6-oxo-5,7-dihydrobenzo[d][1]benzazepin-7-yl]-N'-(2,2,3,3,3-pentafluoropropyl)propanediamide
| CAS No. | 847925-91-1 |
|---|---|
| MDL No. | N/A |
| MF | C22H20F5N3O3 |
| MW | 469.40 |
| InChI Key | OJPLJFIFUQPSJR-INIZCTEOSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
RO4929097 is a dibenzoazepine amide formed by the formal condensation of the carboxy group of 2,2-dimethyl-3-oxo-3-[(2,2,3,3,3-pentafluoropropyl)amino]propanoic acid with the amino group of (7S)-7-amino-5,7-dihydrodibenzo[b,d]azepin-6-one. It acts as an EC 3.4.23.46 (memapsin 2) inhibitor and is classified as a dibenzoazepine, lactam, organofluorine compound, and dicarboxylic acid diamide.
| CAS No. | 847925-91-1 |
|---|---|
| Product Name | 2,2-dimethyl-N-[(7S)-6-oxo-5,7-dihydrobenzo[d][1]benzazepin-7-yl]-N'-(2,2,3,3,3-pentafluoropropyl)propanediamide |
Biological Targets
APH1A·PSENEN·APH1B·PSEN1·NCSTN·
Associated Conditions
breast cancer·colorectal adenocarcinoma·Fallopian Tube Carcinoma·malignant colon neoplasm·neoplasm·
* The information provided here is compiled from public sources and is for reference only.
